𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109

✍ Scribed by Peter J. Van Veldhuizen; James R. Faulkner; Primo N. Lara; Paul H. Gumerlock; J. Wendall. Goodwin; Shaker R. Dakhil; Howard M. Gross; Robert C. Flanigan; E. David. Crawford

Book ID
105992116
Publisher
Springer
Year
2005
Tongue
English
Weight
217 KB
Volume
56
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II trial of interferon-Ξ± and 5-f
A phase II trial of interferon-Ξ± and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
✍ Laurence Elias; Brent A. Blumenstein; Julie Kish; Robert C. Flanigan; James L. W πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 355 KB πŸ‘ 1 views

## BACKGROUND. Renal cell carcinoma is a common neoplasm that is often refractory to treatment. It is occasionally responsive to immunoniodulating agents including interferon-a, which enhances the effects of 5-fluorouracil upon cells. Combinations of these two drugs have been most frequently tested

Phase II trial of carboplatin and paclit
Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma : A Southwest Oncology Group study
✍ Ulka N. Vaishampayan; James R. Faulkner; Eric J. Small; Bruce G. Redman; Wayne L πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## BACKGROUND The purpose of the study was to assess the efficacy and toxicity of carboplatin and paclitaxel administered every 3 weeks in patients with advanced urothelial carcinoma, previously treated with cisplatin‐based therapy. ## METHODS Eligibility included metastatic or local